
Overview
Richard Lock practices practicing medicine in Sydney, Australia.
Mr. Lock is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Glucocorticoid Resistance, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Adult T-Cell Leukemia.
He is actively involved in clinical research, co-authoring 145 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Richard B. Lock
Is Richard B. Lock a top-rated expert for Glucocorticoid Resistance?
MediFind is an objective health platform that identifies experts based on real-world data. Richard B. Lock is classified as an Elite expert for Glucocorticoid Resistance, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Richard B. Lock participate in research or clinical trials?
Yes. Richard B. Lock has published 145 articles and abstracts on conditions like Glucocorticoid Resistance. You can view a list of Richard B. Lock's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Lymphoblastic Leukemia (ALL)
- Glucocorticoid Resistance
- Distinguished
- Adult T-Cell LeukemiaMr. Lock isDistinguished. Learn about Adult T-Cell Leukemia.
- Embryonal Tumor with Multilayered Rosettes
- LeukemiaMr. Lock isDistinguished. Learn about Leukemia.
- RhabdomyosarcomaMr. Lock isDistinguished. Learn about Rhabdomyosarcoma.
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Lock isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMr. Lock isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Cerebral HypoxiaMr. Lock isAdvanced. Learn about Cerebral Hypoxia.
- Ewing SarcomaMr. Lock isAdvanced. Learn about Ewing Sarcoma.
- Gliomatosis CerebriMr. Lock isAdvanced. Learn about Gliomatosis Cerebri.
- NeuroblastomaMr. Lock isAdvanced. Learn about Neuroblastoma.
- OsteosarcomaMr. Lock isAdvanced. Learn about Osteosarcoma.
- Rhabdoid TumorMr. Lock isAdvanced. Learn about Rhabdoid Tumor.
- Wilms TumorMr. Lock isAdvanced. Learn about Wilms Tumor.
- Experienced
- Childhood Acute Myeloid LeukemiaMr. Lock isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Delayed GrowthMr. Lock isExperienced. Learn about Delayed Growth.
- GliomaMr. Lock isExperienced. Learn about Glioma.
- MedulloblastomaMr. Lock isExperienced. Learn about Medulloblastoma.
- PIK3CA-Related Overgrowth SpectrumMr. Lock isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Renal Cell Carcinoma (RCC)Mr. Lock isExperienced. Learn about Renal Cell Carcinoma (RCC).